glp-1 science Science's 2023 Breakthrough of the Year: Weight loss drugs with a real shot at fighting obesity | Unlocking the Genetics of GLP-1

The prevailing consensus from donation organizations is that individuals with either type 1 or type 2 diabetes can generally donate blood and plasma, provided their condition is well-managed and they are in good overall health

2,13 In more severe cases, complications such as gastroparesis, pancreatitis, and GI bleeding may occur

Dual agonists are thought to be more effective at lowering blood sugar and weight loss than GLP-1 RAs alone

Illinois Medicaid reimburses APRNs at 100% of physician rates for all services a progressive policy that makes NP practice financially competitive

In 2021 - 2022, a stronger dose, weekly injectable formulation of Semaglutide (brand name Wegovy) was approved by the US FDA as a medication for weight loss in patients with at least one weight related medical issue